Interview with Matteo Liguori: «Everything will depend on tests on subjects at risk»
Source: la Repubblica
TG 1, interview with Piero Di Lorenzo TG 1 – 15th April
TG1 PRESENTER We now have Piero Di Lorenzo on the line. He is the Managing Director of the company of Pomezia that developed the Coronavirus vaccine together with Oxford University. Good morning Mr. Di Lorenzo, what stage are we at…
Coffee Break, interview with Piero Di Lorenzo La7 – 15th April
ANDREA PANCANI Right Claudia, I just need to ask you to be patient for a moment because next up I have Paolo Sottocorona and the commercial break, and then I want to talk to the man of the moment, as…
Porta a Porta, interview with Piero Di Lorenzo Rai 1 – 14th April
BRUNO VESPA We have with us the CEO of Advent IRBM. There has been a lot a noise about this company that is based near Rome, in Pomezia, because together with a prestigious institute in Oxford, it has developed a…
Human trials will begin soon Canale 5 TG5 – 13th April
TG5 PRESENTER A collaboration between an Italian company from Pomezia and an institute of Oxford University promises to give great results on the vaccine front. In facts human trials are due to begin soon, so what’s new? The new development…
A race against time TGCOM24 – 12th April
TGCOM 24 12th April 2020 Because we were hoping that, once reached the peak, having got the famous plateau, the downward trajectory would be quite steady and fast. Instead we are whilst the numbers are falling each day, they are…
